Neurodegenerative disorders

Rare Guillain-Barre syndrome variant may be linked to AZ vaccine

A rare variant of Guillain-Barré syndrome (GBS) may be linked to the Oxford-AstraZeneca Vaxzevria COVID-19 vaccine, according to UK neurologists. Dr Guendalina Beatrice Bonifacio and colleagues at the Wessex Neurological Centre, University Hospital Southampton NHS Foundation Trust, highlight what they say are five “remarkably similar” cases of bifacial weakness with paraesthesia (BFP), which developed up ...

Already a member?

Login to keep reading.

© 2021 the limbic